Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and regulatory success at both ...

A sharply dressed queue of people lined up for red-carpet photos in front of a step-and-repeat banner emblazoned with logos of corporate ... owned by pharma giant Sanofi, and Edelman, the world ...

Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...

Global and Fortune 500 companies and world-class real estate portfolios recognized for catalyzing people-first places and organizations in 2024Barclays, CBRE, Cisco, Citi Global, EDGE Technologies, Em ...

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio deep B-cell ...

The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

(Reuters) - Sanofi on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its ...

Sanofi is buying an immunology drug from Dren Bio, Inc. for up to $1.9 billion, in a deal it said will help it become a ...

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that provide a clearer look at how the Teva-partnered prospect compares to Merck ...

BRIDGEWATER, N.J., March 14, 2025 /PRNewswire/ -- Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing ...